Biobusiness grants help develop Minnesota businesses and infrastructure to deliver regenerative medicine products and services. Learn more about how to apply for a biobusiness grant by reading our frequently asked questions.
View bio business grants awarded by year.
Timothy O'Brien, DVM, PhD
We have developed a technically simple, scalable, cGMP‐compatible method to generate hyaline cartilage from human induced pluripotent stem cells.…
2020-2021
Wesley Wierson, PhD
LEAH Labs is bringing regenerative immunotherapy to dogs. We use gene editing to enable the translation of cell therapies from successful…
2020-2021
Dave Roeser
We have seven specific milestones with the goal of making bone morphogenetic protein and fibronectin (used to promote bone repair) that is…
2020-2021
Timothy O'Brien, DVM, PhD
We have developed a technically simple, scalable, cGMP‐compatible method to generate hyaline cartilage from human induced pluripotent stem cells.…
2020-2021
Amir Naqwi, PhD
We are proposing the development of an airway cell sprayer that would be included in the instrument channel of a bronchoscope for depositing viable…
2020-2021
Maria Athanasiou, PhD
Building on successful primate model studies, MarPam Pharma is developing a one‐time treatment for durable remission of HIV in the absence of…
2020-2021
Patrick Walsh, MS
The goal of this grant is to bring Anatomi Corp's Chrono™ Platform to market. A small portion of this funding will offset overhead costs associated…
2019-2020
Neil Otto, PhD
The ultimate goal is to provide our gene transfer transposon/transposase platforms to the rapidly growing field of gene modified cell therapy. B‐…
2019-2020
Timothy O'Brien, DVM, PhD
We have developed a novel technology that induces human stem cells to form cartilage. In this project we aim to take the first steps in developing…
2019-2020
Richard Murphy, General Manager
The aim of this grant proposal is to develop cardiovascular devices at Vascudyne with regenerative engineered tissue technology licensed from the…
2019-2020
Ohad Gafni, PhD
Our goal is to engineer a humanized swine model that carries key human cytokines, this strategy will provide the immunology field a high capacity…
2019-2020
Dominique Davidow, PhD
Perfusion decellularization and recellularization are patented technologies owned by Miromatrix Medical Inc. Upon complete removal of cellular…
2019-2020